My mother's sleep medication is a fall risk and her doctor doesn't seem concerned. What programs exist that could help her sleep without the medication?

Your Concern Is Justified — Here's the Evidence

If your mother's doctor isn't raising the issue, that doesn't mean the risk isn't real. Research published in the Journal of General Internal Medicine found that physicians often avoid deprescribing discussions even with patients who have already experienced falls — describing such conversations as "potentially contentious" and sometimes deferring them to pharmacists. The gap between what guidelines say and what happens in a routine 15-minute appointment is well documented.

The falls data makes the stakes clear:

The PMC review of zolpidem safety documents a 4.28-fold increased fall risk in patients taking it and a relative risk of 1.92 for hip fractures. Older adults using sedative-hypnotics face a 3× increased risk of dizziness, balance loss, and falls compared to non-users. These are not obscure findings — they are why the American Geriatrics Society placed Z-drugs on the Beers Criteria list of medications to avoid in older adults.

A hip fracture is not just a broken bone. One in five older adults who suffer a hip fracture does not return to their baseline level of functioning one year later. Early mortality rates within the first year post-hip fracture range from 8% to 36% in the literature. The fall your mother hasn't had yet is the one worth preventing.

Why Doctors Sometimes Don't Act — and What You Can Do About It

Research is candid about the barriers to deprescribing sleep medication in older adults:

• Physicians avoid the conversation. A qualitative study of primary care physicians found they perceived deprescribing discussions as contentious, especially with patients who have been on a medication for years and believe it is helping them. Some doctors felt it was "better suited to others" like pharmacists.
• Patients don't connect the medication to the risk. The same study found patients often had poor understanding of how seriously a fall could affect their independence and quality of life — and didn't perceive themselves as personally at risk.
• No alternative is offered. A doctor who raises "stop taking this" without offering something in its place faces immediate patient resistance. When the conversation doesn't include a concrete treatment plan, it often doesn't happen at all.

This means your role as a family member is genuinely important. You can bring the evidence, request the conversation, and — critically — arrive with an alternative already identified. That changes the dynamic from "take something away" to "replace it with something better."

How to Have a More Productive Conversation with Her Doctor

These specific facts tend to move the needle in clinical conversations about sleep medication and fall risk:

What Programs Can Actually Replace Sleep Medication

There are three categories of programs worth knowing about. What distinguishes them is how much clinical backing, human support, and adaptive personalization they offer — all of which matter more for an older adult on a concurrent medication taper than for someone with mild, uncomplicated insomnia.

Why CBT-I Is the Right Alternative — Not Just Another Pill

The concern that makes this search different from a general sleep program search is the medication dependence. Simply switching to a different pill — melatonin, trazodone, an antihistamine — doesn't solve the problem. It either carries its own fall risks in older adults (antihistamines have strong anticholinergic effects that can cause confusion and dizziness) or replaces one medication with another that still doesn't address why she isn't sleeping.

CBT-I addresses the mechanism of insomnia — the hyperarousal, conditioned wakefulness, and depleted sleep drive that keep older adults awake — rather than chemically suppressing the problem each night. The Trauer et al. 2015 meta-analysis in the Annals of Internal Medicine reviewed 20 randomized controlled trials and found CBT-I produced sustained improvements in sleep onset, sleep efficiency, and time awake — with benefits that persisted and often improved after treatment ended. No sleep medication has an equivalent long-term profile.

Crucially, AASM guidelines on insomnia management explicitly state that "medication tapering and discontinuation are facilitated by CBT-I" and recommend that patients receive CBT-I during long-term pharmacotherapy whenever possible. Your mother's best chance of successfully getting off her medication is to have the behavioral foundation in place before the medication is reduced — not after.

CBT-I has also been shown effective specifically in older adult populations. A July 2025 randomized controlled trial published in npj Digital Medicine enrolled 311 participants aged 55–95 in a digital CBT-I program and found significant improvements in insomnia severity, sleep quality, and fatigue at 6-month and 12-month follow-up. Age is not a barrier to CBT-I.

What Sleep Reset Offers for Older Adults in This Situation

For an older adult who is actively on sleep medication and needs to taper, the most important feature of any program is not automation — it is human oversight. Sleep Reset's dedicated human coaches review your mother's nightly sleep diary, communicate with her daily, and adjust the protocol as the taper progresses. This level of responsive, personalized support is the difference between completing a CBT-I program and abandoning it during the hardest phase.

Sleep Reset also includes licensed sleep medicine clinicians. If her insomnia has an underlying medical component — sleep apnea is frequently undiagnosed in older women and commonly presents as insomnia — home sleep testing and physician evaluation can identify this before spending months on a behavioral program that's treating the wrong problem.

Sleep Reset is designed to be used alongside her current medication and alongside her doctor's taper plan. The CBT-I program runs in parallel with whatever her physician prescribes. The coach is aware of her medication status and accounts for it when calibrating sleep restriction. Her doctor manages the taper; the coach manages the behavioral protocol. This is not a replacement for her doctor — it's the clinical tool that makes her doctor's deprescribing plan work.

On cost: The CBT-I coaching program is paid out-of-pocket and is HSA/FSA eligible. Insurance through select plans including Aetna, Blue Cross Blue Shield, and Anthem covers Sleep Reset's clinical services — licensed clinician visits, home sleep testing, and sleep apnea treatment. Check eligibility here.

Frequently Asked Questions

What if my mother has been on this medication for years and is dependent on it?

Long-term use is common — one large cohort study found 68% of zolpidem users were taking it beyond the FDA-approved short-term window, with a median supply of 192 days. Dependence doesn't make coming off impossible; it makes the taper more gradual and the need for concurrent CBT-I more important. The behavioral changes CBT-I establishes reduce rebound insomnia severity and make longer-term abstinence sustainable. Her physician manages the taper timeline; Sleep Reset supports the process on the behavioral side.

What if her doctor refuses to change her prescription?

You have several options. First, request a medication review specifically focused on fall risk — some practices route this through a clinical pharmacist, which can be less charged than a direct physician conversation. Second, ask for a referral to a sleep medicine specialist, who is better positioned to both validate the concern and propose a structured taper with CBT-I support. Third, your mother can start Sleep Reset's CBT-I program now, while still on medication — this is explicitly how it's designed to work. Building the behavioral foundation first means she'll be in a much stronger position when the taper does happen.

What if she's resistant to changing something that "works"?

This is the most common barrier. The medication feels like it's working because she's sleeping — she may not connect dizziness or balance issues to it. A few reframes that tend to help:

• The medication is helping her sleep; CBT-I will replace what the medication is doing, not just remove it.
• She doesn't need to stop anything before starting — she begins CBT-I while still taking the medication.
• The dizziness she's experiencing is the medication still in her system when she gets up at night. That risk exists every night until the medication changes.
• A broken hip from a nighttime fall typically ends independence more decisively than insomnia does. The math of risk matters here.

Is CBT-I hard for older adults to do?

The most demanding component — sleep restriction — requires limiting time in bed during the initial weeks, which temporarily increases daytime fatigue. This is expected and is the mechanism working correctly. In older adults, the minimum sleep window is set at 5.5 hours (not the 5-hour floor used in younger adults) and titration is more gradual. A dedicated sleep coach calibrates this carefully and adjusts in real time based on her sleep diary. The 2025 RCT in adults aged 55–95 enrolled participants up to age 95 and found CBT-I effective across the full age range.

What if her insomnia is caused by pain, anxiety, or other health conditions?

CBT-I has been studied in older adults with a wide range of comorbidities — chronic pain, cancer, cardiovascular disease, depression, and anxiety — and remains effective. A November 2025 meta-analysis in JAMA Internal Medicine covering 67 RCTs in chronic disease populations found CBT-I effect sizes for insomnia severity of g = 0.98, with low dropout rates and no significant adverse events. Health conditions are not a reason to avoid CBT-I; they are a reason to ensure the program has clinical oversight — which is why Sleep Reset's inclusion of licensed sleep medicine physicians matters specifically for this population.

What are the signs that the fall risk from her medication is getting worse?

Signs that warrant urgent conversation with her doctor include: episodes of dizziness or unsteadiness specifically in the first half of the night or upon getting up from bed (classic residual drug effect); near-falls or actual falls; reports of morning grogginess or mental fogginess that persists into the day; and any confusion or disorientation upon waking. The 2021 systematic review on zolpidem and balance dysfunction found that even at the recommended 5 mg dose for elderly women, the drug impairs balance. If she has been prescribed 10 mg — which many older adults are, despite the FDA recommendation — the risk is materially higher.